Intracranial Delivery Strategies for CAR-T Cell Therapy in Glioblastoma: A Systematic Review of Techniques, Biological Rationale, and Translational Evidence | Synapse
March 8, 2026Open Access
Intracranial Delivery Strategies for CAR-T Cell Therapy in Glioblastoma: A Systematic Review of Techniques, Biological Rationale, and Translational Evidence
Puntos clave
To evaluate various techniques for delivering CAR-T cells directly to the brain in glioblastoma treatment.
Systematic review of existing literature on CAR-T cell therapies in glioblastoma.
Assessment of different intracranial delivery techniques and their biological implications.
Evaluation of translational evidence supporting these delivery strategies.
Identified multiple intracranial delivery methods including surgical and non-surgical techniques.
Highlighted the biological rationale behind using these strategies for enhanced therapeutic outcomes.
Translational evidence suggests potential improvements in glioblastoma patient responses using these techniques.
Resumen
Intracranial Delivery Strategies for CAR-T Cell Therapy in Glioblastoma: A Systematic Review of Techniques, Biological Rationale, and Translational Evidence